A pilot randomized controlled trial of Kisoboka, a behavioral economic and motivational interviewing intervention to reduce high‐risk alcohol use and improve antiretroviral therapy adherence for men in Uganda.

Saved in:
Bibliographic Details
Title: A pilot randomized controlled trial of Kisoboka, a behavioral economic and motivational interviewing intervention to reduce high‐risk alcohol use and improve antiretroviral therapy adherence for men in Uganda.
Authors: Kiene, Susan M. (AUTHOR), Miller, Amanda P. (AUTHOR), Ediau, Michael (AUTHOR), Tuhebwe, Doreen (AUTHOR), Sileo, Katelyn M. (AUTHOR), Naigino, Rose (AUTHOR), Hahn, Judith A. (AUTHOR), Reed, Elizabeth (AUTHOR), Anecho, Asha (AUTHOR), Mukasa, Barbara (AUTHOR), Lin, Chii‐Dean (AUTHOR), Wanyenze, Rhoda K. (AUTHOR), Tumwesigye, Nazarius Mbona (AUTHOR)
Source: Addiction. Jan2026, Vol. 121 Issue 1, p94-107. 14p.
Subjects: Motivational interviewing, Patient compliance, Men, Self-evaluation, Antiretroviral agents, Phospholipids, Research funding, Pilot projects, Statistical sampling, Food security, Behavior, HIV infections, Treatment effectiveness, Randomized controlled trials, Alcohol-induced disorders, Highly active antiretroviral therapy, Fishing, Odds ratio, Drugs, Confidence intervals
Geographic Terms: Sub-Saharan Africa, Uganda
Abstract: Aims: We assessed the feasibility and preliminary efficacy of a multilevel intervention (Kisoboka) to reduce high‐risk alcohol use and improve human immunodeficiency virus (HIV) treatment engagement among fisherfolk men in Uganda. Design: A parallel individually randomized controlled pilot trial with follow‐up at 3 and 6 months. Setting: Five HIV clinics near Ugandan fishing communities. Participants: 160 men (80 per arm), aged 18–50, living with HIV, reporting suboptimal antiretroviral therapy (ART) adherence and high‐risk alcohol use, enrolled between January 2021 and March 2022. Intervention: Kisoboka applies behavioral economic principles and motivational interviewing to address contextual determinants of alcohol use and suboptimal HIV treatment through counseling sessions, text reminders about savings and health goals, and a structural component of assistance setting up mobile money accounts and use of mobile money to receive work pay. The comparator arm (S&R) received only brief alcohol screening feedback, referrals for alcohol counseling and HIV treatment counseling. Measurements High‐risk alcohol use assessed via phosphatidylethanol (PEth) level at baseline and 6 months and Alcohol Use Disorders Identification Test ‐ Consumption (AUDIT‐C) (cutoff ≥9) at baseline, 3 and 6 months. Self‐reported ART adherence (≥90% versus <90%) assessed at baseline, 3 and 6 months. Secondary outcomes: number of days with ≥5 drinks in the prior 28 days and HIV viral load. We assessed intervention fidelity by audio recording and transcribing sessions, then coding a random 20% sample for fidelity to protocol elements. Findings Retention (92.5% completed all sessions) and fidelity (92.8–100% across sessions) were high. Relative to the comparator arm, PEth values decreased from baseline to 6‐month follow‐up in the Kisoboka arm [difference in change −126.87 ng/ml, 95% confidence interval (CI) = −264.29 to 10.55], which was a small effect size (adjusted time* arm interaction: d = 0.14). The proportion with AUDIT‐C ≥9 decreased more in the Kisoboka arm between baseline and 6 months (−26.01%, 95% CI = −36.09% to −15.93%), a medium effect size time*arm effect (d = 0.68). Kisoboka did not improve adherence but protected against declines in optimal adherence observed in the S&R arm (difference in change: 20.96%, 95% CI = 7.15% to 34.77%), which was a medium effect size time*arm effect (d = 0.51). Conclusions: The Kisoboka multilevel intervention to reduce high‐risk alcohol use appears to be feasible; it showed promising clinically meaningful small to medium size effects on reducing high‐risk alcohol use and protected against decreases in antiretroviral therapy adherence in a setting with strong contextual determinants of behavior. [ABSTRACT FROM AUTHOR]
Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 190304750
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A pilot randomized controlled trial of Kisoboka, a behavioral economic and motivational interviewing intervention to reduce high‐risk alcohol use and improve antiretroviral therapy adherence for men in Uganda.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kiene%2C+Susan+M%2E%22&quot;&gt;Kiene, Susan M.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Miller%2C+Amanda+P%2E%22&quot;&gt;Miller, Amanda P.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ediau%2C+Michael%22&quot;&gt;Ediau, Michael&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Tuhebwe%2C+Doreen%22&quot;&gt;Tuhebwe, Doreen&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Sileo%2C+Katelyn+M%2E%22&quot;&gt;Sileo, Katelyn M.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Naigino%2C+Rose%22&quot;&gt;Naigino, Rose&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Hahn%2C+Judith+A%2E%22&quot;&gt;Hahn, Judith A.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Reed%2C+Elizabeth%22&quot;&gt;Reed, Elizabeth&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Anecho%2C+Asha%22&quot;&gt;Anecho, Asha&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mukasa%2C+Barbara%22&quot;&gt;Mukasa, Barbara&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Lin%2C+Chii‐Dean%22&quot;&gt;Lin, Chii‐Dean&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Wanyenze%2C+Rhoda+K%2E%22&quot;&gt;Wanyenze, Rhoda K.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Tumwesigye%2C+Nazarius+Mbona%22&quot;&gt;Tumwesigye, Nazarius Mbona&lt;/searchLink&gt; (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Addiction%22&quot;&gt;Addiction&lt;/searchLink&gt;. Jan2026, Vol. 121 Issue 1, p94-107. 14p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Motivational+interviewing%22&quot;&gt;Motivational interviewing&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Patient+compliance%22&quot;&gt;Patient compliance&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Men%22&quot;&gt;Men&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Self-evaluation%22&quot;&gt;Self-evaluation&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Antiretroviral+agents%22&quot;&gt;Antiretroviral agents&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Phospholipids%22&quot;&gt;Phospholipids&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Research+funding%22&quot;&gt;Research funding&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Pilot+projects%22&quot;&gt;Pilot projects&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Statistical+sampling%22&quot;&gt;Statistical sampling&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Food+security%22&quot;&gt;Food security&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Behavior%22&quot;&gt;Behavior&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22HIV+infections%22&quot;&gt;HIV infections&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Treatment+effectiveness%22&quot;&gt;Treatment effectiveness&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Randomized+controlled+trials%22&quot;&gt;Randomized controlled trials&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Alcohol-induced+disorders%22&quot;&gt;Alcohol-induced disorders&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Highly+active+antiretroviral+therapy%22&quot;&gt;Highly active antiretroviral therapy&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Fishing%22&quot;&gt;Fishing&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Odds+ratio%22&quot;&gt;Odds ratio&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Drugs%22&quot;&gt;Drugs&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Confidence+intervals%22&quot;&gt;Confidence intervals&lt;/searchLink&gt;
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Sub-Saharan+Africa%22&quot;&gt;Sub-Saharan Africa&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Uganda%22&quot;&gt;Uganda&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Aims: We assessed the feasibility and preliminary efficacy of a multilevel intervention (Kisoboka) to reduce high‐risk alcohol use and improve human immunodeficiency virus (HIV) treatment engagement among fisherfolk men in Uganda. Design: A parallel individually randomized controlled pilot trial with follow‐up at 3 and 6 months. Setting: Five HIV clinics near Ugandan fishing communities. Participants: 160 men (80 per arm), aged 18–50, living with HIV, reporting suboptimal antiretroviral therapy (ART) adherence and high‐risk alcohol use, enrolled between January 2021 and March 2022. Intervention: Kisoboka applies behavioral economic principles and motivational interviewing to address contextual determinants of alcohol use and suboptimal HIV treatment through counseling sessions, text reminders about savings and health goals, and a structural component of assistance setting up mobile money accounts and use of mobile money to receive work pay. The comparator arm (S&amp;R) received only brief alcohol screening feedback, referrals for alcohol counseling and HIV treatment counseling. Measurements High‐risk alcohol use assessed via phosphatidylethanol (PEth) level at baseline and 6 months and Alcohol Use Disorders Identification Test ‐ Consumption (AUDIT‐C) (cutoff ≥9) at baseline, 3 and 6 months. Self‐reported ART adherence (≥90% versus &lt;90%) assessed at baseline, 3 and 6 months. Secondary outcomes: number of days with ≥5 drinks in the prior 28 days and HIV viral load. We assessed intervention fidelity by audio recording and transcribing sessions, then coding a random 20% sample for fidelity to protocol elements. Findings Retention (92.5% completed all sessions) and fidelity (92.8–100% across sessions) were high. Relative to the comparator arm, PEth values decreased from baseline to 6‐month follow‐up in the Kisoboka arm [difference in change −126.87 ng/ml, 95% confidence interval (CI) = −264.29 to 10.55], which was a small effect size (adjusted time* arm interaction: d = 0.14). The proportion with AUDIT‐C ≥9 decreased more in the Kisoboka arm between baseline and 6 months (−26.01%, 95% CI = −36.09% to −15.93%), a medium effect size time*arm effect (d = 0.68). Kisoboka did not improve adherence but protected against declines in optimal adherence observed in the S&amp;R arm (difference in change: 20.96%, 95% CI = 7.15% to 34.77%), which was a medium effect size time*arm effect (d = 0.51). Conclusions: The Kisoboka multilevel intervention to reduce high‐risk alcohol use appears to be feasible; it showed promising clinically meaningful small to medium size effects on reducing high‐risk alcohol use and protected against decreases in antiretroviral therapy adherence in a setting with strong contextual determinants of behavior. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=190304750
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/add.70169
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 14
        StartPage: 94
    Subjects:
      – SubjectFull: Motivational interviewing
        Type: general
      – SubjectFull: Patient compliance
        Type: general
      – SubjectFull: Men
        Type: general
      – SubjectFull: Self-evaluation
        Type: general
      – SubjectFull: Antiretroviral agents
        Type: general
      – SubjectFull: Phospholipids
        Type: general
      – SubjectFull: Research funding
        Type: general
      – SubjectFull: Pilot projects
        Type: general
      – SubjectFull: Statistical sampling
        Type: general
      – SubjectFull: Food security
        Type: general
      – SubjectFull: Behavior
        Type: general
      – SubjectFull: HIV infections
        Type: general
      – SubjectFull: Treatment effectiveness
        Type: general
      – SubjectFull: Randomized controlled trials
        Type: general
      – SubjectFull: Alcohol-induced disorders
        Type: general
      – SubjectFull: Highly active antiretroviral therapy
        Type: general
      – SubjectFull: Fishing
        Type: general
      – SubjectFull: Odds ratio
        Type: general
      – SubjectFull: Drugs
        Type: general
      – SubjectFull: Confidence intervals
        Type: general
      – SubjectFull: Sub-Saharan Africa
        Type: general
      – SubjectFull: Uganda
        Type: general
    Titles:
      – TitleFull: A pilot randomized controlled trial of Kisoboka, a behavioral economic and motivational interviewing intervention to reduce high‐risk alcohol use and improve antiretroviral therapy adherence for men in Uganda.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kiene, Susan M.
      – PersonEntity:
          Name:
            NameFull: Miller, Amanda P.
      – PersonEntity:
          Name:
            NameFull: Ediau, Michael
      – PersonEntity:
          Name:
            NameFull: Tuhebwe, Doreen
      – PersonEntity:
          Name:
            NameFull: Sileo, Katelyn M.
      – PersonEntity:
          Name:
            NameFull: Naigino, Rose
      – PersonEntity:
          Name:
            NameFull: Hahn, Judith A.
      – PersonEntity:
          Name:
            NameFull: Reed, Elizabeth
      – PersonEntity:
          Name:
            NameFull: Anecho, Asha
      – PersonEntity:
          Name:
            NameFull: Mukasa, Barbara
      – PersonEntity:
          Name:
            NameFull: Lin, Chii‐Dean
      – PersonEntity:
          Name:
            NameFull: Wanyenze, Rhoda K.
      – PersonEntity:
          Name:
            NameFull: Tumwesigye, Nazarius Mbona
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 09652140
          Numbering:
            – Type: volume
              Value: 121
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Addiction
              Type: main
ResultId 1